← SynDRA
LOTAMILAST
SynDRA canonical compound SYN0039186 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PDE4A | PDE4B | PDE4C | PDE4D |
|---|
| Mechanism of action | phosphodiesterase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PDE4A INHIBITOR
- Phosphodiesterase 4 inhibitor
- PDE4D INHIBITOR
- PDE4B INHIBITOR
- PDE4C INHIBITOR
- phosphodiesterase inhibitor
Cross-references
Synonyms
- E-6005
- E6005
- RVT-501
- UNII-TO043KKB9C
- TO043KKB9C
- Methyl 4-((3-(6,7-dimethoxy-2-(methylamino)quinazolin-4-yl)phenyl)carbamoyl)benzoate
- Methyl 4-({3-[6,7-dimethoxy-2-(methylamino)quinazolin-4-yl]phenyl}carbamoyl)benzoate
- Lotamilast [USAN]
- SCHEMBL369445
- CHEMBL3989967
- MolPort-046-033-604
- BCP25249
- EX-A1382
- ZINC113676839
- AKOS027337123
- SB16962
- DB12776
- CS-7517
- (Methyl 4-(((3-(6,7-dimethoxy-2-(methylamino)quinazolin-4-yl)phenyl(amino)carbonyl)benzoate
- HY-12740
- AS-52366
- Benzoic acid, 4-(((3-(6,7
- RVT 501
- lotamilastum
- RefChem:800054
- C26H24N4O5
- MFCD28502071
- LOTAMILAST [INN]
- Lotamilast (USAN/INN)
- LOTAMILAST [WHO-DD]
- orb1303472
- SCHEMBL29373383
- GLXC-10753
- XMB62048
- BDBM50559709
- AC-35466
- NS00073362
- D11305
- E6005?
Look up LOTAMILAST in the interactive SynDRA portal →